220 related articles for article (PubMed ID: 29055972)
1. Chronic obstructive pulmonary disease and β-blocker treatment in Asian patients with heart failure.
Kubota Y; Tay WT; Asai K; Murai K; Nakajima I; Hagiwara N; Ikeda T; Kurita T; Teng TK; Anand I; Lam CSP; Shimizu W;
ESC Heart Fail; 2018 Apr; 5(2):297-305. PubMed ID: 29055972
[TBL] [Abstract][Full Text] [Related]
2. Impact of beta-blocker use on the long-term outcomes of heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Tay WT; Teng TK; Asai K; Noda T; Kusano K; Suzuki A; Hagiwara N; Hisatake S; Ikeda T; Yasuoka R; Kurita T; Shimizu W;
ESC Heart Fail; 2021 Oct; 8(5):3791-3799. PubMed ID: 34189870
[TBL] [Abstract][Full Text] [Related]
3. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry.
MacDonald MR; Tay WT; Teng TK; Anand I; Ling LH; Yap J; Tromp J; Wander GS; Naik A; Ngarmukos T; Siswanto BB; Hung CL; Richards AM; Lam CSP; ;
J Am Heart Assoc; 2020 Jan; 9(1):e012199. PubMed ID: 31852421
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
[TBL] [Abstract][Full Text] [Related]
5. Heart failure with preserved ejection fraction in Asia.
Tromp J; Teng TH; Tay WT; Hung CL; Narasimhan C; Shimizu W; Park SW; Liew HB; Ngarmukos T; Reyes EB; Siswanto BB; Yu CM; Zhang S; Yap J; MacDonald M; Ling LH; Leineweber K; Richards AM; Zile MR; Anand IS; Lam CSP;
Eur J Heart Fail; 2019 Jan; 21(1):23-36. PubMed ID: 30113120
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.
Jaiswal A; Chichra A; Nguyen VQ; Gadiraju TV; Le Jemtel TH
Curr Heart Fail Rep; 2016 Feb; 13(1):30-6. PubMed ID: 26780914
[TBL] [Abstract][Full Text] [Related]
7. Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study.
Chandramouli C; Tay WT; Bamadhaj NS; Tromp J; Teng TK; Yap JJL; MacDonald MR; Hung CL; Streng K; Naik A; Wander GS; Sawhney J; Ling LH; Richards AM; Anand I; Voors AA; Lam CSP;
PLoS Med; 2019 Sep; 16(9):e1002916. PubMed ID: 31550265
[TBL] [Abstract][Full Text] [Related]
8. Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.
Dewan P; Jhund PS; Shen L; Petrie MC; Abraham WT; Atif Ali M; Chen CH; Desai AS; Dickstein K; Huang J; Kiatchoosakun S; Kim KS; Køber L; Lai WT; Liao Y; Mogensen UM; Oh BH; Packer M; Rouleau JL; Shi V; Sibulo AS; Solomon SD; Sritara P; Swedberg K; Tsutsui H; Zile MR; McMurray JJV
Eur J Heart Fail; 2019 May; 21(5):577-587. PubMed ID: 30536678
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive airway disease among patients hospitalized with acute heart failure; clinical characteristics, precipitating factors, management and outcome: Observational report from the Middle East.
Khafaji HA; Sulaiman K; Singh R; Alhabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; Almahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; Faleh HA; Elasfar A; Panduranga P; Suwaidi JA
Acute Card Care; 2015 Dec; 17(4):55-66. PubMed ID: 27712142
[TBL] [Abstract][Full Text] [Related]
10. The clinical characteristics and outcomes of heart failure patient with chronic obstructive pulmonary disease from the Japanese community-based registry.
Takabayashi K; Terasaki Y; Okuda M; Nakajima O; Koito H; Kitamura T; Kitaguchi S; Nohara R
Heart Vessels; 2021 Feb; 36(2):223-234. PubMed ID: 32770265
[TBL] [Abstract][Full Text] [Related]
11. Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.
Dewan P; Docherty KF; Bengtsson O; de Boer RA; Desai AS; Drozdz J; Hawkins NM; Inzucchi SE; Kitakaze M; Køber L; Kosiborod MN; Langkilde AM; Lindholm D; Martinez FA; Merkely B; Petrie MC; Ponikowski P; Sabatine MS; Schou M; Sjöstrand M; Solomon SD; Verma S; Jhund PS; McMurray JJV
Eur J Heart Fail; 2021 Apr; 23(4):632-643. PubMed ID: 33368858
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T
Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135
[TBL] [Abstract][Full Text] [Related]
13. Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES.
Yeoh SE; Dewan P; Serenelli M; Ferreira JP; Pitt B; Swedberg K; van Veldhuisen DJ; Zannad F; Jhund PS; McMurray JJV
Eur J Heart Fail; 2022 Mar; 24(3):529-538. PubMed ID: 34536265
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease.
Guazzi M; Myers J; Vicenzi M; Bensimhon D; Chase P; Pinkstaff S; Arena R
Am Heart J; 2010 Nov; 160(5):900-5. PubMed ID: 21095278
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and management of COPD and heart failure comorbidity in the general practitioner setting.
Pirina P; Martinetti M; Spada C; Zinellu E; Pes R; Chessa E; Fois AG; Miravitlles M;
Respir Med; 2017 Oct; 131():1-5. PubMed ID: 28947013
[TBL] [Abstract][Full Text] [Related]
16. Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?
Ege MR; Guray U; Guray Y; Yilmaz MB; Yucel O; Zorlu A; Tandogan I
Herz; 2012 Nov; 37(7):796-800. PubMed ID: 22699995
[TBL] [Abstract][Full Text] [Related]
17. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
18. Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry.
Lam CS; Teng TK; Tay WT; Anand I; Zhang S; Shimizu W; Narasimhan C; Park SW; Yu CM; Ngarmukos T; Omar R; Reyes EB; Siswanto BB; Hung CL; Ling LH; Yap J; MacDonald M; Richards AM
Eur Heart J; 2016 Nov; 37(41):3141-3153. PubMed ID: 27502121
[TBL] [Abstract][Full Text] [Related]
19. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications.
Mascarenhas J; Lourenço P; Lopes R; Azevedo A; Bettencourt P
Am Heart J; 2008 Mar; 155(3):521-5. PubMed ID: 18294490
[TBL] [Abstract][Full Text] [Related]
20. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
